|
|
Drugs for Chagas Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 171)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Lopinavir | approved | Phase 4, Phase 2, Phase 3 | 342 | 192725-17-0 | 92727 | (1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI) 192725-17-0 1mui 2o4s 2q5k 2rkf 2rkg A 157378 A 157378.0 A-157378-0 A-157378.0 AB1 ABT 157378 ABT 378 ABT-378 ABT-378, LOPINAVIR AC1L3OPJ AIDS032937 | Aluviran C12871 C37H48N4O5 CHEBI:40456 CHEMBL729 CID92727 D01425 DB01601 Koletra LPV LS-173766 Lopinavir Lopinavir (JAN/USAN/INN) Lopinavir [USAN:INN:BAN] MolPort-003-848-410 N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE NCGC00164576-01 NCGC00164576-02 RS-346 S1380_Selleck UNII-2494G1JF75 | |
| | 2 | | Rifampin | approved | Phase 4, Phase 3, Phase 2 | 337 | 13292-46-1 | 5458213, 5381226 | 1-b]furan-21-yl acetate 13292-46-1 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV 3-(4-Methylpiperazinyliminomethyl)rifamycin SV 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin 46713_FLUKA 46713_RIEDEL 62534-43-4 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV 8-(4-Methylpiperazinyliminomethyl) rifamycin SV 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv 83907_FLUKA 83907_SIGMA 8CI) AZT + Rifampin Abrifam Archidyn Arficin Arzide BA-41166E BIDD:PXR0014 BPBio1_000561 BSPBio_000509 Ba 41166 Ba 41166/E Benemicin Benemycin Bio-0621 C06688 C43H58N4O12 CAS-13292-46-1 CCRIS 551 CHEBI:28077 CHEBI:455936 CHEMBL180 CID5381226 CID5388984 CID5458213 CID5702112 CID6604339 CID6708473 CID6842115 CID6912767 CID6913622 CPD001906767 D00211 DB01045 DRG-0109 Dione 21-acetate Dipicin DivK1c_000550 Doloresum EINECS 236-312-0 Eremfat Famcin Fenampicin HMS1569J11 HMS1920P08 HMS2089F12 HMS2092G09 HMS501L12 HSDB 3181 KBio1_000550 KBio2_000919 KBio2_003487 KBio2_006055 KBio3_003018 KBioGR_001780 KBioSS_000919 L-5103 L-5103 Lepetit LS-7689 MLS000028552 MLS001148237 MLS001333745 MolPort-000-767-051 MolPort-002-513-586 MolPort-003-666-281 MolPort-006-395-891 NCGC00016699-01 NCGC00017365-01 NCGC00018178-01 NCGC00022678-03 NCGC00022678-04 NCGC00022678-05 NCGC00160500-01 | NCI60_000309 NINDS_000550 NSC 113926 NSC-113926 NSC113926 Piperine & Rifampicin Prestwick0_000525 Prestwick1_000525 Prestwick2_000525 Prestwick3_000525 Prestwick_833 R-Cin R/AMP R0079 R3501_SIAL R3501_SIGMA R5777_SIGMA R7382_SIGMA RAMP RFP RMP Ramp Reserpine & Rifampicin Rf Rfamipicin Rifa Rifadin Rifadin (TN) Rifadin I.V Rifadin I.V. Rifadin IV Rifadin Iv Rifadin, Rimactane, Rifampicin, Rifampin Rifadine Rifagen Rifaldazin Rifaldazine Rifaldin Rifam Rifamicin AMP Rifamor Rifampicin Rifampicin & EEP Rifampicin & Propolis Rifampicin (JP15/INN) Rifampicin SV Rifampicin [INN:BAN:JAN] Rifampicina Rifampicina [INN-Spanish] Rifampicine Rifampicine [French] Rifampicinum Rifampicinum [INN-Latin] Rifampin Rifampin (USP) Rifampin [USAN] Rifamsolin Rifamycin Rifamycin AMP Rifamycin Amp Rifaprodin Rifcin Rifinah Rifobac Rifoldin Rifoldine Riforal Rimactan Rimactane Rimactane (TN) Rimactazid Rimactin Rimactizid Rimazid Rimycin Rofact S1764_Selleck SAM002264646 SMR000058322 SMR000653525 SPBio_002430 SPECTRUM1500529 STK080143 Sinerdol Spectrum3_001837 Spectrum4_001250 Spectrum5_002018 Spectrum_000439 TNP00313 Tubocin UNII-VJT6J7R4TR WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1 nchembio884-comp4 rifampin |
| | 3 | | Warfarin | approved | Phase 4 | 454 | 81-81-2 | 6691, 54678486 | (-)-Warfarin (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone (S)-Warfarin (phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin (phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine 1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone 200 Coumarin 200 coumarin 3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin 3-(Acetonylbenzyl)-4-hydroxycoumarin 3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin 3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin 3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin 4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine 4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin 4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine 4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin 4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine 4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine 4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine 45706_FLUKA 45706_RIEDEL 4oh-coumarin deriv. 5543-56-6 5543-57-7 81-81-2 A2250_FLUKA A2250_SIGMA AC-15978 AC1L1N37 AC1Q6AN3 AR-1E2310 Arab Rat Death Arab rat death Arab rat deth Athrombin Athrombin-K Athrombin-k Athrombine-K Athrombine-k BRD-A24514565-001-02-2 BRD-A24514565-236-01-6 BRN 1293536 BSPBio_002026 Bio-0586 Brumolin C01541 C19H16O4 CBDivE_002127 CBDivE_013236 CBKinase1_000192 CBKinase1_012592 CHEBI:10033 CHEMBL1464 CID6691 CO-Rax Caswell No. 903 Choice Choice (TN) Co-Rax Co-rax Compound 42 Coumadin Coumadin Tabs Coumafen Coumafene Coumafene [French] Coumaphen Coumaphene Coumarins Coumefene Cov-R-Tox Cov-R-tox D-Con D08682 DB00682 DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin Dethmor Dethnel Dicusat E Dicusat e DivK1c_000444 EINECS 201-377-6 EINECS 226-907-3 EPA Pesticide Chemical Code 086002 Eastern states duocide Fasco fascrat powder Frass-Ratron Frass-ratron HMS1921K07 HMS2092C20 HMS501G06 HSDB 1786 I14-0958 IDI1_000444 Jantoven KBio1_000444 KBio2_000674 KBio2_003242 KBio2_005810 KBio3_001526 KBioGR_000901 KBioSS_000674 Killgerm sewarin p Kumader Kumadu Kumatox Kypfarin LS-55083 Latka 42 Latka 42 [Czech] Liqua-tox MLS001304042 Maag Rattentod Cum Maag rattentod cum Mar-Frin Mar-frin Marevan Martin'S mar-frin Martin's mar-frin | Maveran MolPort-001-787-822 Mouse pak NCGC00094810-01 NCGC00094810-02 NCGC00159398-03 NCGC00178855-01 NINDS_000444 NSC 59813 NSC59813 PS104_SUPELCO Panwarfin Place-Pax Place-pax Prothromadin RAX RCR grey squirrel killer concentrate RCRA waste no. P001 Rat & mice bait Rat and mice bait Rat-B-gon Rat-Gard Rat-Kill Rat-Mix Rat-O-cide #2 Rat-O-cide no. 2 Rat-Ola Rat-Trol Rat-a-way Rat-alpha-way Rat-b-gon Rat-beta-gon Rat-gard Rat-kill Rat-mix Rat-o-cide #2 Rat-ola Rat-trol Ratorex Ratox Ratoxin Ratron Ratron G Ratron g Rats-no-more Ratten-Koederrohr Ratten-koederrohr Rattenstreupulver Neu Schacht Rattenstreupulver neu schacht Rattenstreupulver new schacht Rattentraenke Rattunal Rcra waste number P001 Ro-Deth Ro-deth Rodafarin Rodafarin C Rodafarin c Rodex Rodex blox Rosex Rough & ready mouse mix Rough and ready mouse mix SMP1_000316 SMR000718754 SPBio_000870 SPECTRUM1500613 STK364490 Sakarat Sewarin Sofarin Solfarin Sorexa Plus Sorexa plus Spectrum2_000935 Spectrum3_000583 Spectrum4_000381 Spectrum5_001751 Spectrum_000194 Spray-trol brand roden-trol Temus W Temus w Tintorane Tox-Hid Tox-hid Twin light rat away UNII-5Q7ZVV76EI Vampirinip II Vampirinip III Vampirinip iii W.A.R.F. 42 WARF compound 42 WLN: T66 BOVJ DYR&1V1 EQ Waran Warf 10 Warf 42 Warfarat Warfarin (INN) Warfarin (and salts of) Warfarin Plus Warfarin Q Warfarin [BSI:ISO] Warfarin [INN:BAN] Warfarin plus Warfarin plus [discontinued] Warfarin sodium Warfarin titrated to an INR of 2.5-3.0 Warfarin(R) Warfarina Warfarina [INN-Spanish] Warfarine Warfarine [INN-French] Warfarine [ISO-French] Warfarinum Warfarinum [INN-Latin] Warficide Warfilone Zoocoumarin Zoocoumarin [Netherlands and USSR] Zoocoumarin [Russian] delta-Con nchembio.307-comp19 rac-Warfarin warfarin | |
| | 4 | | Enalaprilat | approved | Phase 4 | 120 | 76420-72-9 | 6917719 | (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate 76420-72-9 AC1NUWEA AC1OCEK7 BIDD:GT0752 C11720 C18H24N2O5.2H2O CHEBI:116759 CHEBI:42302 CHEBI:4786 CHEBI:59877 CHEMBL1200697 CHEMBL577 CID5462501 CID6917719 CPD000466359 D03769 EAL ENALAPRILAT INHIBITOR Enalapril acid Enalapril diacid Enalaprilat Enalaprilat (USP) | Enalaprilat anhydrous Enalaprilate Enalaprilatum Enalaprilic acid Enalprilate hydrate HMS2051H16 HMS2089P04 LS-118903 LS-187219 MK-422 MLS000759476 MLS001424138 MolPort-005-943-792 N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline--water (1/2) N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline—water (1/2) NCGC00164593-01 S1657_Selleck SAM001246684 SBB065733 SMR000466359 Vasotec I.V. enalaprilat dihydrate enalaprilat hydrate enalprilat hydrate enalprilate hydrate | |
| | 5 | | Enalapril | approved, vet_approved | Phase 4 | 120 | 75847-73-3 | 5362032, 40466924 | (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline (S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester 75847-73-3 AC1NTUS5 Analapril BIDD:GT0751 BPBio1_000340 BSPBio_000308 BSPBio_003035 Bonuten C06977 CAS-76095-16-4 CHEBI:116847 CHEBI:4784 CHEMBL578 CID5388962 D07892 DivK1c_000408 Enalapril Enalapril (INN) Enalapril (TN) Enalapril Bp Enalapril Maleate Enalapril Richet Enalaprila Enalaprila [INN-Spanish] Enalaprilat Enalaprilum | Enalaprilum [INN-Latin] Gadopril HMS2090E08 IDI1_000408 KBio1_000408 KBio2_001787 KBio2_004355 KBio2_006923 KBio3_002535 KBioGR_000355 KBioSS_001787 Kinfil LS-190651 MolPort-002-885-877 N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline NCGC00016932-01 NCGC00021569-04 NCGC00021569-05 NCGC00021569-06 NINDS_000408 Prestwick3_000314 SPBio_001349 Spectrum2_001455 Spectrum3_001478 Spectrum4_000008 Spectrum5_001107 Spectrum_001307 Vaseretic Vasotec Vasotec IV enalapril |
| | 6 | | Ritonavir | approved, investigational | Phase 4, Phase 2, Phase 3 | 870 | 155213-67-5 | 392622 | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate 155213-67-5 1hxw 1sh9 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 538, ABT A-84538 ABBOTT-84538 ABT 538 ABT 84538 ABT-538 ABT538 AC-733 AC1L94GB AKOS000280930 Abbott 84538 BIDD:GT0387 BIDD:PXR0023 Bio-0093 C07240 C37H48N6O5S2 CHEBI:45409 CHEMBL163 CID392622 CPD000466395 D00427 D019438 | DB00503 DRG-0244 FT-0082824 HMS2051B08 HSDB 7160 LS-148860 MLS000759541 MLS001424063 MolPort-000-883-877 N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide NCGC00159462-02 NSC693184 Norvir Norvir (TM) Norvir (TN) Norvir Sec RIT RTV Ritonavir Ritonavir (JAN/USAN/INN) Ritonavir [USAN] Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavirum S1185_Selleck SAM001246783 SMR000466395 STK634209 ZINC03944422 ritonavir | |
| | 7 | | Emtricitabine | approved, investigational | Phase 4, Phase 3 | 439 | 143491-57-0 | 60877 | (-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-.beta.-L-FTC (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-2'-Deoxy-5-fluoro-3'-thiacytidine (-)-FTC (-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone (2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone .beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine 143491-54-7 143491-57-0 145213-48-5 2',3',5-FTC 2',3'-Dideoxy-5-fluoro-3'-thiacytidine 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine 2'-Deoxy-5-fluoro-3'-thiacytidine 2-FTC 3'-Thia-2'.3'-dideoxy-5-fluorocytidine 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine 524W91 AC1L1U3I AC1Q4KUB BW 1592 | BW 524W91 BW-524W91 BW524W91 C122114 C12599 C8H10FN3O3S CHEBI:31536 CHEMBL885 CID60877 Coviracil Coviracil(TM) D01199 DB00879 DRG-0208 Emtricitabin Emtricitabina Emtricitabine Emtricitabine (JAN/USAN/INN) Emtricitabinum Emtriva Emtriva (TN) Emtriva(TM) FT-0080009 HMS2089I05 HSDB 7337 LS-135838 LS-173184 NCGC00164564-01 RCV Racivir SBB066061 TL8000958 UNII-G70B4ETF4S ZINC03629271 beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine dOTFC emtricitabine |
| | 8 | | Zidovudine | approved | Phase 4, Phase 3, Phase 2 | 494 | 30516-87-1 | 35370 | -Azido-3&prime -deoxythymidine 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine 3&prime 3' Azido 2',3' Dideoxythymidine 3' Azido 3' deoxythymidine 3'-Azido-2',3'-Dideoxythymidine 3'-Azido-3'-deoxythymidine 3'-Azido-3'-deoxythymidine & Concanavalin A 3'-Azido-3'-deoxythymidine & Erythropoietin 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19 3'-Azido-3'-deoxythymidine & Interleukin-1 3'-Azido-3'-deoxythymidine & Interleukin-2 3'-Azido-3'-deoxythymidine & Interleukin-6 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon 3'-Azido-3'-deoxythymidine & Sho-Saiko-To 3'-Azido-3'-deoxythymidine (AIDS) 3'-Azido-3'deoxythymidine & Interferon .alpha. 3'-Azidothymidine 3'-Deoxy-3'-azidothymidine 3'-azido-3'-deoxythymidine, AZT 3-Azido-3-deoxythymidine 30516-87-1 399024-19-2 A2169_SIGMA AC1L1TKL AC1Q2OEK AZT AZT & CD4(178)-PE 40 AZT & Colony-stimulating factor 2 AZT & Concanavalin A (ConA) AZT & EPO AZT & GM-CSF AZT & HPA AZT & IFN.alpha. AZT & IL-1 AZT & IL-2 AZT & IL-6 AZT & Interferon-.alpha.-2 AZT & Li & EPO AZT & Li & GM-CSF AZT & Li & IL-1 AZT & Li & IL-6 AZT & Lymphoblastoid Interferon AZT & NP (from PHCA or HSA) AZT & PM-19 AZT & SST AZT & rIFN.alpha.2 AZT & rsCD4 & rIFN.alpha.A AZT & rsT4 AZT & sCD4 AZT & srCD4 AZT (Antiviral) AZT Antiviral AZT TRANSPLACENTAL CARCINOGENESIS STUDY AZT+PRO 140 AZT, Antiviral Antiviral AZT Apo-Zidovudine Azidothymidine Aztec BB_NC-1012 BPBio1_000403 BRD-K72903603-001-04-6 BSPBio_000365 BSPBio_003153 BW A509U BW-A 509U BW-A-509U BW-A509U BWA 509U BWA-509U BWA509U C07210 CCRIS 105 CHEBI:10110 CHEBI:127307 CHEMBL129 CID35370 | CPD000058351 Compound S Cpd S D00413 D015215 DB00495 DRG-0004 DS-4152 & AZT DivK1c_000524 HMS1921J20 HMS2090G11 HMS2092D06 HMS501K06 HSDB 6515 IDI1_000524 Interferon AD + 3'-azido-3'-deoxythymidine Intron A & AZT K7 [P Ti2 W10 O40] KBio1_000524 KBio2_001828 KBio2_004396 KBio2_006964 KBio3_002653 KBioGR_000703 KBioSS_001828 LS-1159 Liposomal AZT-SN-1 Liposomal AZT-SN-3 MLS000028548 MLS001055351 MLS001076358 MLS002153202 MLS002222249 Met-SDF-1.beta. & AZT Met-SDF-1.beta. & Zidovudine MolPort-002-507-286 NCGC00023945-03 NCGC00023945-04 NCGC00023945-05 NCGC00023945-08 NCGC00178237-01 NCGC00178237-02 NINDS_000524 NSC 602670 Novo-Azt PC-SOD+AZT Prestwick3_000333 Propolis+AZT Racemic Liposomal AZT Retrovir Retrovir (TN) Retrovir(TM) SAM002548971 SMR000058351 SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SPBio_000834 SPECTRUM1502109 STK801891 Spectrum2_000927 Spectrum3_001507 Spectrum4_000332 Spectrum5_001101 Spectrum_001348 UNII-4B9XT59T7S ZDV ZIDOVUDINE [AZT] ZINC03779042 ZVD Zidovudin Zidovudina Zidovudina [Spanish] Zidovudine (JAN/USP/INN) Zidovudine EP III Zidovudine [USAN:INN:BAN:JAN] Zidovudine+PRO 140 Zidovudinum Zidovudinum [Latin] antiviral azidodeoxythymidine rIFN-beta seron & AZT racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle) zidovudin zidovudine |
| | 9 | | Lamivudine | approved, investigational | Phase 4, Phase 3, Phase 2 | 613 | 134678-17-4 | 60825 | (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (+/-)-3TC (+/-)-BCH-189 (+/-)-SddC (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-2'-Deoxy-3'-thiacytidine (-)-BCH 189 (-)-BCH-189 (-)-SddC (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine (-)NGPB-21 (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To 134678-17-4 2',3' Dideoxy 3' thiacytidine 2',3'-Dideoxy-3'-thiacytidine 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA) 3'-Thia-2',3'-dideoxycytidine 3TC 3TC & GNA 3TC & SST 3TC (AIDS INITIATIVE) (AIDS INITIATIVE) 3TC and NV-01 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 480434-79-5 AC-1416 AC1L1TZZ AC1Q6C34 BCH 189 BCH-189 BCH-790 BCH189 BIDD:GT0033 Bio-0652 C07065 C8H11N3O3S CCRIS 9274 CHEBI:133986 CHEMBL141 CID60825 CPD000466319 D00353 D019259 | DB00709 DRG-0126 DTHC Epivir Epivir (TN) Epivir(TM) Epivir-HBV Epzicom FT-0082667 GG-714 GR 109714X GR-109714X GR109714X HHA & 3TC HHA & Lamivudine HMS2051D21 HSDB 7155 Hepitec Heptivir Heptodin Heptovir L0217 LMV LS-2107 Lamivir Lamivudin Lamivudina Lamivudine Lamivudine & GNA Lamivudine (JAN/USP/INN) Lamivudine [USAN:BAN:INN] Lamivudine [USAN:INN:BAN] Lamivudine [Usan:Ban:Inn] Lamivudine, (2S-cis)-Isomer Lamivudinum MLS000759424 MLS001424097 MolPort-002-507-347 NCGC00159341-03 NCGC00159341-04 NSC620753 S1706_Selleck SAM001246582 SAM002589994 SMR000466319 STK801940 UNII-2T8Q726O95 ZINC00012346 Zeffix Zefix beta-L-2',3'-Dideoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine lamivudine |
| | 10 | | Didanosine | approved | Phase 4, Phase 3 | 150 | 69655-05-6 | 50599 | 149409-57-4 2',3'-Dideoxyinosine 2',3'-Dideoxyinosine & Granulocyte-macrophage colony-stimulating factor 2',3'-Dideoxyinosine & Interferon-.alpha. 2',3'-Dideoxyinosine & sCD4(soluble recombinant protein) 2',3'-Dideoxyinosine (AIDS Initiative) 2',3'-Dideoxyinosine (ddI) 2',3'-dideoxyinosine, DDI, NSC 612049, Didanosine 2'3'-DIDEOXYINOSINE 2,3-Dideoxyinosine 2,3-dideoxyinosine 2DI 3'-Azido-3'-deoxythymidine + 2',3'-Dideoxyinosine 69655-05-6 9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine 9-(2,3-Dideoxy-beta-D-ribofuranosyl)hypoxanthine 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE 9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one AC-12026 AC1L19ET AC1L3OPK BMY 40900 BMY-40900 BRN 3619529 Benzeneethanamine, 4-methoxy-3-(2-phenylethoxy)-N,N-dipropyl-, hydrochloride Bio-0685 C06953 C083832 CCRIS 805 CHEBI:490877 CHEMBL1460 CID119381 CID50599 CPD000058576 D00296 D2I D3066 DB00900 DB02392 DDI DDI and rIFN.alpha.2 DIDEOXYINOSINE DRG-0016 DS-4152 & ddI DdIno Didanosina | Didanosina [INN-Spanish] Didanosine Didanosine (JAN/USAN/INN) Didanosine and Interferon-.alpha.-2 Didanosinum Didanosinum [INN-Latin] Dideoxyinosine Dideoxyinosine (DDI) FT-0082664 HMS2051J11 HMS2089N20 HSDB 6548 Hypoxanthine ddN Inosine, 2',3'-dideoxy- & Recombinant Interferon-.alpha.-2 Intron A & Videx KS-1049 LOA & ddI Listera ovata agglutinin & 2',3'-Dideoxyinosine MLS000759469 MLS001055350 MLS001424118 MLS002154216 MolPort-002-507-371 MolPort-002-885-819 N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride N,N-diethyl-2-(4-methoxy-3-phenethyloxyphenyl)ethanamine hydrochloride NCGC00090691-01 NCGC00159514-02 NCGC00159514-03 NCGC00164280-01 NE 100 NE-100 NSC 612049 NSC-612049 NSC612049 PC-SOD+ddI S1702_Selleck SAM001246673 SMR000058576 Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine UNII-K3GDH6OH08 Videx Videx (TN) Videx EC Videx EC(TM)(slow-release capsules) Videx(TM) ZINC13597823 ddI & GM-CSF ddI & IFN-.alpha. ddI & sCD4(rsCD4) ddI + d4T combination ddIno didanosine | |
| | 11 | | Tenofovir | approved, investigational | Phase 4, Phase 3, Phase 2 | 733 | 147127-20-6 | 464205 | (R)-9-(2-Phosphonomethoxypropyl)adenine (R)-9-(2-Phosphonylmethoxypropyl)adenine (R)-9-(2-phosphonomethoxypropyl)adenine (R)-PMPA 147127-20-6 206184-49-8 AC-760 AC1LA9BO Anh. tenofovir Anhydrous tenofovir Apropovir CHEBI:45809 CHEMBL483 CID464205 D,L-Tenofovir DB00300 GNA & Tenofovir GS 1275 GS 1278 GS1278 | HHA & Tenofovir KS-5021 MolPort-003-850-411 NCGC00167535-01 PMPA PMPA-(R) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI) Phosphonic acid, [[2-(6-amino-9H-purin-9 S1401_Selleck TDF TFV Tenefovir Tenofovir Tenofovir (anh.) Tenofovir disoproxil Tenofovir disoproxil fumarate UNII-99YXE507IL Viread Viread, Tenofovir [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid |
| | 12 | | Carvedilol | approved, investigational | Phase 4 | 163 | 72956-09-3 | 2585 | (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol 107741-96-8 72956-09-3 AB1004830 AC-1641 AC1L1E0B Artist Artist (TN) Atlana Pharma brand of carvedilol BM 14190 BM-14-190 BM-14.190 BM-14190 BRD-A10977446-001-04-8 BRD-A10977446-045-01-1 Bio-0014 C043211 C06875 C2260 C24H26N2O4 CHEBI:3441 CHEMBL723 CID2585 CPD000449280 Carvedilol Carvedilol (JAN/USAN/INN) Carvedilol [USAN:INN:BAN:JAN] Carvedilolum Carvedilolum [Latin] Coreg Coreg (TN) Coreg CR Coropres Coropress D00255 DB01136 DQ 2466 DQ-2466 Dibloc | Dilatrend EG-P042 Eucardic GlaxoSmithKline brand of carvedilol HMS2051N03 HMS2089B09 HMS2093E12 HSDB 7044 I06-0064 I06-1477 KBio2_002145 KBio2_004713 KBio2_007281 KBio3_002323 KBioGR_001252 KBioSS_002145 Kredex L001243 LS-121875 Lakeside brand of carvedilol MLS000758299 MLS000759508 MLS001424092 MolPort-003-666-814 NCGC00167832-01 NCGC00167832-02 NCGC00167832-03 Querto Roche brand of carvedilol SAM001246736 SAM001247021 SK&F-105517 SKF 105517 SMR000449280 SPBio_001885 STK621453 Spectrum2_001673 Spectrum3_001182 Spectrum4_000636 Spectrum5_001436 Spectrum_001665 TL8005080 UNII-0K47UL67F2 carvedilol carvedilol, (+-)-isomer carvedilol, (R)-isomer carvedilol, (S)-isomer carvedilol, 14C-labeled |
| | 13 | | Efavirenz | approved, investigational | Phase 4, Phase 3, Phase 2 | 405 | 154598-52-4 | 64139 | (-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (-)-Efavirenz (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one 154598-52-4 1ikv 1ikw 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9 6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one AC-19049 AC1L20IX BIDD:GT0383 C08088 C14H9ClF3NO2 CHEBI:119486 CHEMBL223228 CID64139 CPD000466351 D00896 DB00625 DB07709 DMP 266 DMP-266 EFV | EFZ Efavirenz Efavirenz (JAN/INN) Efavirenzum Eravirenz HMS2051J08 HMS2090N16 HSDB 7163 L 743726 L-741211 L-743,726 L-743725 L-743726 LS-173464 MLS000759465 MLS001424087 Met-SDF-1.beta. & Efavirenz Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz MolPort-003-983-924 NSC742403 SAM001246667 SBB066062 SMR000466351 Stocrin Strocin (TM) Sustiva Sustiva (TM) Sustiva (TN) UNII-JE6H2O27P8 ZINC02020233 efavirenz efavirenz, (S)-isomer zoxazin-2-one Éfavirenz |
| | 14 | | Aspirin | approved, vet_approved | Phase 4 | 1112 | 50-78-2 | 2244 | 11126-35-5 11126-37-7 1oxr 2-(ACETYLOXY)benzoic acid 2-(Acetyloxy)benzoate 2-(Acetyloxy)benzoic acid 2-Acetoxybenzenecarboxylic acid 2-Acetoxybenzoate 2-Acetoxybenzoic acid 2-Carboxyphenyl acetate 2349-94-2 26914-13-6 50-78-2 8-hour Bayer 98201-60-6 A 5376 A.S.A A.S.A. A.S.A. Empirin A.S.A. empirin A2093_SIGMA A3160_SIGMA A5376_SIGMA A6810_SIGMA AB1003266 AC 5230 AC1L1D8U AC1Q1LA0 ACETYLSALICYLIC ACID AI3-02956 AIN AKOS000118884 ASA Acenterine Acesal Acetal Acetard Aceticyl Acetilsalicilico Acetilum acidulatum Acetisal Acetol Acetonyl Acetophen Acetosal Acetosalic acid Acetosalin Acetoxybenzoic acid Acetylin Acetylsal Acetylsalicylate Acetylsalicylic acid Acetylsalicylsaeure Acetylsalicylsaure Acetylsalycilic acid Acetyonyl Acetysal Acetysalicylic acid Acide 2-(acetyloxy)benzoique Acide acetylsalicylique Acide acétylsalicylique Acido O-acetil-benzoico Acido acetilsalicilico Acidum acetylsalicylicum Acimetten Acisal Acylpyrin Adiro Aloxiprimum Asacard Asagran Asatard Ascoden-30 Aspalon Aspec Aspergum Aspir-Mox Aspirdrops Aspirin Aspirin (JP15/USP) Aspirin [BAN:JAN] Aspirina 03 Aspirine Asprin Aspro Aspro Clear Asteric Azetylsalizylsaeure Azetylsalizylsäure BIDD:GT0118 BRN 0779271 Bay-e-4465 Bayer Bayer Aspirin 8 Hour Bayer Buffered Bayer Extra Strength Aspirin For Migraine Pain Bayer Plus Benaspir Bi-prin Bialpirina Bialpirinia Bufferin C01405 CCRIS 3243 CHEBI:15365 CHEMBL25 CID2244 Caprin Cardioaspirin Cardioaspirina Cemirit Claradin Clariprin Colfarit Contrheuma retard Coricidin Crystar D00109 D001241 DB00945 Decaten Delgesic Dispril DivK1c_000555 Dolean pH 8 Duramax ECM EINECS 200-064-1 EU-0100038 Easprin Easprin (TN) Ecolen Ecotrin Empirin Empirin with Codeine Endosprin Endydol | Entericin Enterophen Enterosarein Enterosarine Entrophen Extren Globentyl Globoid HMS1920E13 HMS2090G03 HMS2091K13 HMS501L17 HSDB 652 Helicon I14-7505 IDI1_000555 Idragin Istopirin KBio1_000555 KBio2_001725 KBio2_002271 KBio2_004293 KBio2_004839 KBio2_006861 KBio2_007407 KBio3_002149 KBio3_002751 KBioGR_000398 KBioGR_002271 KBioSS_001725 KBioSS_002272 Kapsazal Kyselina 2-acetoxybenzoova Kyselina acetylsalicylova LS-143 Levius Lopac-A-5376 Lopac0_000038 MLS001055329 MLS001066332 MLS001336045 MLS001336046 Magnecyl Measurin Medisyl Micristin MolPort-000-871-622 NCGC00015067-01 NCGC00015067-04 NCGC00015067-09 NCGC00090977-01 NCGC00090977-02 NCGC00090977-03 NCGC00090977-04 NCGC00090977-05 NCGC00090977-06 NCGC00090977-07 NCI60_002222 NINDS_000555 NSC 27223 NSC27223 NSC406186 Neuronika Novid Nu-seals Nu-seals aspirin O-(Acetyloxy)benzoate O-(Acetyloxy)benzoic acid O-Acetoxybenzoate O-Acetoxybenzoic acid O-Acetylsalicylic acid O-Carboxyphenyl acetate O-accetylsalicylic acid O-acetylsalicylic acid PL-2200 Persistin Pharmacin Pirseal Polopirin Polopiryna Premaspin R16CO5Y76E [UNII] Rheumin tabletten Rheumintabletten Rhodine Rhonal Ronal S-211 SMR000059138 SP 189 SPBio_001838 SPECTRUM1500130 ST075414 Salacetin Salcetogen Saletin Salicylic acid acetate Salicylic acid, acetate Salospir Solfrin Solprin Solprin acid Solpyron Solupsan Spectrum2_001899 Spectrum3_001295 Spectrum4_000099 Spectrum5_000740 Spectrum_001245 Spira-Dine St. Joseph St. Joseph Aspirin for Adults Supac Tasprin Temperal Toldex Triaminicin Triple-sal UNII R16CO5Y76E UNII-R16CO5Y76E UNII=R16CO5Y76E UNM-0000306102 Vanquish WLN: QVR BOV1 XAXA Xaxa Yasta ZORprin aspirin cMAP_000006 component of Midol component of Synirin nchem.859-comp6 o-Acetoxybenzoic acid o-Carboxyphenyl acetate o-acetoxybenzoic acid o-carboxyphenyl acetate ácido acetilsalicílico | |
| | 15 | | Pyrazinamide | approved | Phase 4, Phase 3, Phase 2 | 89 | 98-96-4 | 1046 | 2-Carbamylpyrazine 2-Pyrazinecarboxamide 2-carbamyl pyrazine 2-carbamylpyrazine 2-pyrazinecarboxamide 5-25-04-00178 (Beilstein Handbook Reference) 82612_FLUKA 98-96-4 AB00052083 AC-907/25014068 AC1L1ALT AC1Q4ZGM AKOS000120280 AZT + Pyrazinamide combination Aldinamid Aldinamide BB_SC-1250 BIDD:GT0228 BPBio1_000515 BRN 0112306 BSPBio_000467 BSPBio_002572 Braccopiral C01956 C5H5N3O CAS- 98-96-4 CCRIS 545 CHEBI:45285 CHEMBL614 CID1046 CPD000036662 Corsazinmid D-50 D-50 (VAN) D00144 D011718 DB00339 DRG 0124 Dipimide DivK1c_000241 EINECS 202-717-6 EU-0101011 Eprazin Farmizina HMS1569H09 HMS1920N08 HMS2092E09 HMS500M03 HSDB 3576 I14-6758 IDI1_000241 InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9 Isopas KBio1_000241 KBio2_001382 KBio2_003950 KBio2_006518 KBio3_001792 KBioGR_001851 KBioSS_001382 LS-2053 Lopac-P-7136 Lopac0_001011 Lynamide MK 56 MLS000069730 MLS002222347 MolPort-001-770-770 NCGC00015833-01 NCGC00015833-02 NCGC00015833-05 NCGC00015833-10 NCGC00090695-01 NCGC00090695-03 NCGC00090695-04 NCGC00090695-05 NCGC00090695-06 | NCGC00090695-07 NCI-C01785 NINDS_000241 NSC 14911 NSC14911 Novamid P 7136 P ezetamid P0633 P7136_SIGMA PZA Pezetamid Pharozinamide Piraldina Pirazimida Pirazinamid Pirazinamida Pirazinamida [INN-Spanish] Pirazinamide Pirazinamide [DCIT] Pirilene Prazina Prestwick0_000514 Prestwick1_000514 Prestwick2_000514 Prestwick3_000514 Prestwick_811 Pyrafat Pyramide Pyrazide Pyrazinamdie Pyrazinamid Pyrazinamida Pyrazinamide Pyrazinamide (JP15/USP/INN) Pyrazinamide (TN) Pyrazinamide BP 2000 Pyrazinamide [INN:BAN:JAN] Pyrazinamidum Pyrazinamidum [INN-Latin] Pyrazine carboxamide Pyrazine carboxylamide Pyrazineamide Pyrazinecarboxamide Pyrazinecarboxylic acid amide Pyrazinoic acid am ide Pyrazinoic acid amide Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide Pyrizinamide Rifater Rozide S1762_Selleck SAM002554927 SMR000036662 SPBio_001369 SPBio_002388 SPECTRUM1500518 STK801661 Spectrum2_001305 Spectrum3_001046 Spectrum4_001186 Spectrum5_001026 Spectrum_000902 T 165 Tebrazid Tebrazio Tisamid UNII-2KNI5N06TI Unipyranamide WLN: T6N DNJ BVZ ZINC00002005 Zinamide Zinastat pms-Pyrazinamide pyrazinamide pyrazine carboxylamide pyrazine-2-carboxamide pyrazinecarboxamide pyrazinoic acid amide |
| | 16 | | Ethambutol | approved | Phase 4, Phase 3, Phase 2 | 82 | 74-55-5 | 3279, 14052 | (+)-(S,S)-2,2'-(1,2-Ethylenediimino)-di-1-butanol (+)-2,2'-(Ethylenediimino)di-1-butanol (+)-2,2'-(ethylenediimino)di-1-butanol (+)-N,N'-Bis(1-(hydroxymethyl)propyl)ethylenediamine (+)-N,N'-bis(1-(hydroxymethyl)propyl)ethylenediamine (+)-S,S-Ethambutol (+)-S,S-ethambutol (+)-ethambutol (-)-(R,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol (2'S)-2,2'-[Ethane-1,2-diyldi(imino)]dibutan-1-ol (2R)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol (2R)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol (2S)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol (2S)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol (2S,2'S)-2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol (2S,7S)-2,7-Diethyl-3,6-diazaoctane-1,8-diol (2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol (R)-2,2'-(1,2-Ethanediyldiimino)bis-1-butanol (S,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol (S,S)-Ethambutol (S,S)-ethambutol 1070-11-7 2,2'-(1,2-Ethylenediimino)-di-1-butanol 2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol 2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol 74-55-5 75343-56-5 AC1L1FKQ AC1L230T AC1L9YT2 AC1LABPH AC1LAKIP AC1LAKIS AC1Q2C85 AC1Q2SHV AC1Q77PZ AR-1A7805 AR-1C2065 Aethambutolum BPBio1_000105 BSPBio_000095 BSPBio_002012 C06984 C10H24N2O2 CAS-1070-11-7 CHEBI:4877 CHEMBL43824 CHEMBL44884 CID14052 CID3279 CID465436 CID470071 CID470072 CID504259 CL 40881 (dihydrochloride) CPD000046147 D-2,2'-(Ethylenediimino)bis(1-butanol) D-2,2'-(Ethylenediimino)di-1-butanol D-Ethambutol D-N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine D07925 DB00330 Dadibutol Diambutol | DivK1c_000561 EINECS 200-810-6 EMB Etambutol Etambutol [INN-Spanish] Etambutolo Etambutolo [DCIT] Ethambutol Ethambutol & EEP Ethambutol & Propolis Ethambutol (INN) Ethambutol HCL Ethambutol Hydrochloride Ethambutol [INN:BAN] Ethambutol dihydrochloride Ethambutol, (-)-isomer Ethambutol, meso form Ethambutol, racemic mixture Ethambutolum Ethambutolum [INN-Latin] Etibi HSDB 3078 IDI1_000561 KBio1_000561 KBio2_001538 KBio2_004106 KBio2_006674 KBio3_001232 KBioGR_001209 KBioSS_001538 KST-1A8084 LS-187119 LS-46537 MLS000082702 Miambutol MolPort-002-507-956 MolPort-003-847-110 Myambutol Myambutol (dihydrochloride) NCGC00016560-01 NCGC00178864-01 NCGC00179661-01 NINDS_000561 NSC653313 Prestwick0_000028 Prestwick1_000028 Prestwick2_000028 Prestwick3_000028 Purderal S,S-Ethambutol SAM002589988 SMR000046147 SPBio_001167 SPBio_002016 STK711105 STOCK5S-98432 Servambutol Servambutol (TN) Spectrum2_001014 Spectrum3_000426 Spectrum4_000545 Spectrum5_000702 Spectrum_001058 Tibutol UNII-8G167061QZ d,N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine ethambutol |
| | 17 | | Isoniazid | approved | Phase 4, Phase 3, Phase 2 | 150 | 54-85-3 | 3767 | 37271-10-6 4-pyridinecarbohydrazide 41466-07-3 5015 R.P 5015 R.P. 5015 RP 54-85-3 62229-51-0 7640-37-1 AB00052025 AC1L1GNZ AC1Q54UP AC1Q54UQ AI3-23936 AKOS000119062 AZT + Isoniazid Abdizide Andrazide Anidrasona Antimicina Antituberkulosum Armacide Armazid Armazide Atcotibine Azuren BB_SC-6246 BIDD:GT0140 BP 5015 BPBio1_000025 BPBio1_001322 BSPBio_000021 BSPBio_002204 Bacillin Biomol-NT_000288 C07054 C6H7N3O CAS-54-85-3 CCRIS 351 CHEBI:6030 CHEMBL64 CID3767 CPD000059082 Cedin Cedin (Aerosol) Cemidon Chemiazid Chemidon Continazine Cortinazine Cotinazin Cotinizin D00346 D007538 DB00951 Defonin Dibutin Diforin Dinacrin Ditubin DivK1c_000070 Dow-Isoniazid EINECS 200-214-6 Ebidene Eralon Ertuban Eutizon Evalon FRS-3 FSR 3 FSR-3 Fetefu Fimalene GINK HIA HMS1568B03 HMS1920H09 HMS2089I16 HMS2091N19 HMS500D12 HSDB 1647 Hid rasonil Hidranizil Hidrasonil Hidrulta Hidrun Hycozid Hydra Hydrazid Hydrazide Hyozid Hyzyd I.A.I I.A.I. I0138 I14-9731 I3377_FLUKA I3377_SIGMA IDI1_000070 INH INHd20 Ido-tebin Idrazil In-73 Inah Inh-Burgthal Inizid Iscotin Isidrina Ismazide Isobicina Isocid Isocidene Isocotin Isohydrazide Isokin Isolyn Isonerit Isonex Isoniacid Isoniazid Isoniazid & EEP Isoniazid & Propolis Isoniazid SA Isoniazida Isoniazide Isoniazidum Isonicazide Isonicid Isonico Isonicotan Isonicotil Isonicotinhydrazid Isonicotinic acid hydrazide Isonicotinic hydrazide Isonicotinohydrazide Isonicotinoyl hydrazide Isonicotinoylhydrazide Isonicotinsaeurehydrazid Isonicotinyl hydrazide Isonicotinyl hydrazine Isonicotinylhydrazine Isonide Isonidrin Isonikazid Isonilex Isonin Isonindon Isonirit Isoniton Isonizida Isonizide Isopyrin | Isotamine Isotebe Isotebezid Isotinyl Isozid Isozide Isozyd KBio1_000070 KBio2_001333 KBio2_003901 KBio2_006469 KBio3_001424 KBioGR_000423 KBioSS_001333 L 1945 LANIZID LS-205 Laniazid Laniazid (TN) Laniozid MLS000069444 MLS001055327 MolPort-000-141-557 Mybasan NCGC00016244-01 NCGC00016244-02 NCGC00022648-03 NCGC00022648-04 NCGC00022648-05 NCGC00022648-06 NINDS_000070 NSC 9659 NSC9659 Neo-Tizide Neoteben Neoxin Neumandin Nevin Niadrin Nicazide Nicetal Nicizina Niconyl Nicotibina Nicotibine Nicotisan Nicozide Nidaton Nidrazid Nikozid Niplen Nitadon Niteban Nitebannsc 9659 Nydrazid Nyscozid Oprea1_396155 Pelazid Percin Phthisen Preparation 6424 Prestwick0_000161 Prestwick1_000161 Prestwick2_000161 Prestwick3_000161 Prestwick_578 Pycazide Pyreazid Pyricidin Pyridicin Pyridine-4-carboxylic acid hydrazide Pyrizidin RP 5015 RP-5015 RU-EF-Tb RY-EF-Tb Raumanon Razide Retozide Rifamate Rimicid Rimifon Rimiphone Rimitsid Robiselin Robisellin Roxifen S1937_Selleck SAM002554904 SMR000059082 SPBio_000094 SPBio_001942 SPECTRUM1500355 STK086288 Sanohidrazina Sauterazid Sauterzid Spectrum2_000107 Spectrum3_000472 Spectrum4_000022 Spectrum5_000876 Spectrum_000853 Stanozide TB-Phlogin TB-Razide TB-Vis Tebecid Tebenic Tebexin Tebilon Tebos Teebaconin Tekazin Tibazide Tibemid Tibiazide Tibinide Tibison Tibivis Tibizide Tibusan Tisin Tisiodrazida Tizide Tubazid Tubazide Tubeco Tubecotubercid Tuberian Tubicon Tubilysin Tubizid Tubomel Tyvid UNII-V83O1VOZ8L Unicocyde Unicozyde Usaf cb-2 Vazadrine Vederon WLN: T6NJ DVMZ ZINC00001590 Zidafimia Zinadon Zonazide bacillen bp 5 015 isoco tin isoniazid isozid e nchembio884-comp3 nidra zid rimif on tebemid tubercid |
| | 18 | | Etravirine | approved | Phase 4 | 74 | 269055-15-4 | 193962 | 269055-15-4 394729-17-0 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile 65B AC1L4XC5 CHEBI:213138 CHEMBL308954 CID193962 D04112 DAPY deriv DB07191 Diaminopyrimidine deriv Etravirine | Etravirine (JAN/USAN/INN) I06-1887 Intelence Intelence (TN) Intelence(TM) R 165335 R-165335 R165335 R165335-TMC125 ST51053273 TMC 125 TMC-125 TMC-125/R-165335 TMC125 UNII-0C50HW4FO1 ZINC00602632 | |
| | 19 | | Darunavir | approved | Phase 4 | 205 | 635728-49-3, 206361-99-1 | 213039 | (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate 206361-99-1 2f80 2f81 2f8g 2hs1 2hs2 2idw 2ien 3bvb 3cyw 3d1z 3d20 618109-00-5 AC1L4U4V AIDS073035 CHEBI:367163 CHEMBL1323 | CID213039 Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester D03656 DB01264 Darunavir Darunavir (USAN/INN) Darunavir [USAN] Darunavirum Darunavirum [INN-Latin] Darunavirum [INN-latin] LS-187026 LS-187772 LS-191295 MolPort-003-846-141 N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide Prezista Prezista(TM) TMC 114 TMC-114 TMC114 UIC 94017 UIC-94017 UIC-96017 UNII-YO603Y8113 [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester | |
| | 20 | | Pyridoxine | approved, nutraceutical, vet_approved | Phase 4, Phase 3, Phase 2 | 186 | 65-23-6 | 1054 | (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate 12001-78-4 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German] 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine 2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine 2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine 2-methyl-4,5-dimethylol-pyridin-3-ol 2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride 3-Hydroxy-2-Picoline-4,5-dimethanol 3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride 3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride 3-Hydroxy-4,5-dimethylol-alpha-picoline 3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine 4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol 4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride 4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol 4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol 4-Deoxypyridoxine 5'-phosphate 47862_SUPELCO 5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride 5-Hydroxy-6-methyl-3,4-pyridinedimethanol 5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride 5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride 58-56-0 58-56-0 (HCL) 58-56-0 (hydrochloride) 65-23-6 65-23-6 (Parent) 8059-24-3 85078-23-5 AC-12024 AC-14512 AC-907/25014218 AC1L1AMH AC1L1LMI AC1L2XK2 AC1Q22HP AC1Q2G66 AC1Q3F63 AI3-19016 AIDS-006784 AIDS006784 AR-1A6363 AR-1J1632 Adermin hydrochloride Adermine Adermine hydrochloride Aderomine hydrochloride Aderoxin Aderoxine Alestrol BB_NC-0050 BIDD:PXR0180 BPBio1_000646 BSPBio_000586 Becilan Beesix Benadon Bonasanit C00314 C8H11NO3 CAS-58-56-0 CBDivE_015627 CCRIS 1903 CHEBI:16709 CHEBI:30961 CHEMBL1200756 CHEMBL1364 CID104817 CID1054 CID6019 CPD0-1221 Campoviton 6 Cernevit-12 D02179 D025101 D08454 DB00165 EINECS 200-386-2 EINECS 200-603-0 EINECS 232-503-8 Godabion Gravidox HMS1569N08 HMS2093L07 HSDB 1212 Hexa-Betalin Hexa-Betalin (R) Hexa-betalin (TN) Hexabetalin Hexabione hydrochloride | Hexavibex Hexermin Hexermine Hexobion Hydoxin I02-1897 I02-2297 KST-1A8556 LS-134393 LS-187072 LS-2332 MLS001074329 MLS002153915 MolPort-002-137-856 MolPort-002-319-991 MolPort-005-933-330 NCGC00016261-01 NCGC00164317-01 NCGC00180946-01 NSC 36225 NSC36225 NSC36225 (HCL) Nestrex Oprea1_061614 P0561 P4722_SIAL P5669_SIGMA P6280_SIGMA P8666_SIGMA P9755_SIAL PN PN HCl PYRIDOXINE HYDROCHLORIDE PYRIDOXINE HYDROCHLORIDE, U.S.P. Paxadon Piridossina Piridossina [DCIT] Piridoxina Piridoxina [INN-Spanish] Prestwick0_000623 Prestwick1_000623 Prestwick2_000623 Prestwick3_000623 Prestwick_925 Pydox Pyridipca Pyridox Pyridoxin Pyridoxin hydrochloride Pyridoxine Pyridoxine (INN) Pyridoxine HCl Pyridoxine Hydrochloride (B6) Pyridoxine [INN:BAN] Pyridoxine chloride Pyridoxine hydrochloride (JP15/USP) Pyridoxine hydrochloride [USAN:JAN] Pyridoxine hydrogen chloride Pyridoxine monohydrochloride Pyridoxine, hydrochloride Pyridoxine-HCl Microencapsulated Pyridoxinium chloride Pyridoxinum Pyridoxinum [INN-Latin] Pyridoxinum hydrochloricum Pyridoxinum hydrochloricum (Hungarian) Pyridoxol Pyridoxol hydrochloride Pyridoxol, hydrochloride Pyridoxolum Rodex Rodex (R) Rodex TD SMP2_000230 SMR000674613 SPBio_002805 STK177324 STOCK1N-08684 Spondylonal Tex Six T.R. TimTec1_000657 UNII-68Y4CF58BV UNII-KV2JZ1BI6Z Vitamin B 6 Vitamin B6 Vitamin B6-hydrochloride Vitamin V6 Vitamin V6 (TN) Vitamin-?B6 Vitamin-?B6 hydrochloride Vitaped WLN: T6NJ B1 CQ D1Q E1Q &GH ZINC00049154 ZINC21983293 bmse000288 c1302 component of Alestrol nchembio.93-comp1 pyridoxine vitamin B6 |
| | 21 | | Pyridoxal | approved, nutraceutical | Phase 4, Phase 3, Phase 2 | 185 | 66-72-8 | 1050 | 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine 3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde | 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde Piridoxal Pyridoxal Pyridoxaldehyde |
| | 22 | | Anti-Infective Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 21402 | | | | 23 | | Benzonidazole | | Phase 4, Phase 3, Phase 2 | 12 | | | | 24 | | Immunosuppressive Agents | | Phase 4, Phase 3, Phase 2 | 12770 | | | | 25 | | Antiparasitic Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 2127 | | | | 26 | | Antiprotozoal Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 1986 | | | | 27 | | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | | Phase 4, Phase 3 | 237 | | | | 28 | | Cytochrome P-450 CYP2C9 Inhibitors | | Phase 4, Phase 3, Phase 2 | 658 | | | | 29 | | Peripheral Nervous System Agents | | Phase 4, Phase 3 | 22776 | | | | 30 | | Rifamycins | | Phase 4 | 97 | | | | 31 | | Reverse Transcriptase Inhibitors | | Phase 4, Phase 3, Phase 2 | 1880 | | | | 32 | | Antimetabolites | | Phase 4, Phase 3, Phase 2 | 11774 | | | | 33 | | Lamivudine, zidovudine drug combination | | Phase 4, Phase 3 | 111 | | | | 34 | | Antihypertensive Agents | | Phase 4, Phase 3 | 4095 | | | | 35 | | HIV Integrase Inhibitors | | Phase 4, Phase 3, Phase 2 | 387 | | | | 36 | | Atazanavir Sulfate | | Phase 4, Phase 3, Phase 2 | 223 | | | | 37 | | Integrase Inhibitors | | Phase 4, Phase 3, Phase 2 | 408 | | | | 38 | | rifamycin SV | | Phase 4 | 97 | | | | 39 | | Anticoagulants | | Phase 4 | 2516 | | | | 40 | | Adrenergic beta-Antagonists | | Phase 4, Phase 3 | 1154 | | | | 41 | | Anti-Bacterial Agents | | Phase 4, Phase 2, Phase 3 | 10884 | | | | 42 | | Antibiotics, Antitubercular | | Phase 4, Phase 2, Phase 3 | 6972 | | | | 43 | | Vasodilator Agents | | Phase 4 | 3438 | | | | 44 | | protease inhibitors | | Phase 4, Phase 2, Phase 3 | 5320 | | | | | 45 | | Angiotensin-Converting Enzyme Inhibitors | | Phase 4 | 711 | | | | 46 | | HIV Protease Inhibitors | | Phase 4, Phase 2, Phase 3 | 5319 | | | | 47 | | Natriuretic Peptide, Brain | | Phase 4 | 178 | | | | 48 | | Neurotransmitter Agents | | Phase 4, Phase 3 | 17734 | | | | 49 | | Adrenergic Agents | | Phase 4, Phase 3 | 5140 | | | | 50 | | Anti-HIV Agents | | Phase 4, Phase 2, Phase 3 | 3100 | | |
Interventional clinical trials: (show top 50)
(show all 104)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease | Unknown status | NCT01678599 | Phase 4 | | 2 | Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease | Unknown status | NCT01549236 | Phase 4 | | 3 | Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease | Completed | NCT01755403 | Phase 4 | | 4 | Exercise Training in Chagas Cardiomyopathy | Completed | NCT01006473 | Phase 4 | | 5 | A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy | Completed | NCT01557140 | Phase 4 | | 6 | Outcomes of an Anticoagulation Clinic in an University Hospital | Completed | NCT01006486 | Phase 4 | | 7 | An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin | Completed | NCT00771498 | Phase 4 | | 8 | Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis | Completed | NCT00108862 | Phase 4 | | 9 | Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy | Completed | NCT00605098 | Phase 4 | | 10 | HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV | Completed | NCT00442962 | Phase 4 | | 11 | Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings | Completed | NCT00084136 | Phase 4 | | 12 | Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) | Recruiting | NCT01650792 | Phase 4 | | 13 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | Active, not recruiting | NCT01641367 | Phase 4 | | 14 | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment | Active, not recruiting | NCT01380080 | Phase 4 | | 15 | Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease | Terminated | NCT01539161 | Phase 4 | | 16 | Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg | Terminated | NCT00533390 | Phase 4 | | 17 | BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease | Unknown status | NCT00123916 | Phase 3 | | 18 | Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial | Completed | NCT02386358 | Phase 3 | | 19 | Cardiac Rehabilitation in Chagas Heart Failure | Completed | NCT02516293 | Phase 2, Phase 3 | | 20 | Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity | Completed | NCT00323973 | Phase 3 | | 21 | Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women | Completed | NCT01461096 | Phase 3 | | 22 | Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor | Completed | NCT00038519 | Phase 2, Phase 3 | | 23 | Preventing Sexual Transmission of HIV With Anti-HIV Drugs | Completed | NCT00074581 | Phase 3 | | 24 | Study of Options for Second-Line Effective Combination Therapy (SELECT) | Completed | NCT01352715 | Phase 3 | | 25 | A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment | Completed | NCT00004581 | Phase 3 | | 26 | A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy | Completed | NCT00004583 | Phase 3 | | 27 | Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults | Completed | NCT01108510 | Phase 3 | | 28 | Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects | Completed | NCT00146328 | Phase 2, Phase 3 | | 29 | Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. | Completed | NCT01991899 | Phase 3 | | 30 | Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease | Recruiting | NCT02625974 | Phase 3 | | 31 | Selenium Treatment and Chagasic Cardiopathy (STCC) | Recruiting | NCT00875173 | Phase 3 | | 32 | CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY) | Recruiting | NCT02369978 | Phase 2, Phase 3 | | 33 | Low Antimonial Dosage in American Mucosal Leishmaniasis | Recruiting | NCT01301937 | Phase 2, Phase 3 | | 34 | Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults | Recruiting | NCT02344290 | Phase 3 | | 35 | TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens | Recruiting | NCT02410772 | Phase 3 | | 36 | Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment | Recruiting | NCT02548351 | Phase 3 | | 37 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | Recruiting | NCT01435018 | Phase 3 | | 38 | Physical Exercise Program in Chronic Chagas Heart Disease | Active, not recruiting | NCT02517632 | Phase 3 | | 39 | Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis | Active, not recruiting | NCT01301924 | Phase 2, Phase 3 | | 40 | Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection | Active, not recruiting | NCT01404312 | Phase 3 | | 41 | Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma | Active, not recruiting | NCT01352117 | Phase 3 | | 42 | Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment | Active, not recruiting | NCT01818596 | Phase 3 | | 43 | Shortening Treatment by Advancing Novel Drugs | Active, not recruiting | NCT02342886 | Phase 3 | | 44 | Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? | Active, not recruiting | NCT00860977 | Phase 3 | | 45 | Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants | Active, not recruiting | NCT01815736 | Phase 3 | | 46 | Treatment of Asymptomatic Toxocariasis With Albendazole in Children | Active, not recruiting | NCT00755560 | Phase 3 | | 47 | Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis | Terminated | NCT00330148 | Phase 3 | | 48 | Cell Therapy in Chagas Cardiomyopathy | Terminated | NCT00349271 | Phase 3 | | 49 | Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease | Unknown status | NCT01489228 | Phase 2 | | 50 | Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults | Unknown status | NCT01155037 | Phase 2 |
|
